These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
684 related items for PubMed ID: 32221325
1. Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw. Adachi N, Ayukawa Y, Yasunami N, Furuhashi A, Imai M, Sanda K, Atsuta I, Koyano K. Sci Rep; 2020 Mar 27; 10(1):5620. PubMed ID: 32221325 [Abstract] [Full Text] [Related]
2. Therapeutic effect of fluvastatin on medication-related osteonecrosis of the jaw. Sanda K, Ayukawa Y, Yasunami N, Adachi N, Furuhashi A, Imai M, Matsunaka K, Koyano K. J Periodontol; 2022 Jun 27; 93(6):837-846. PubMed ID: 34510440 [Abstract] [Full Text] [Related]
4. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor? Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M. PLoS One; 2018 Jun 27; 13(7):e0201343. PubMed ID: 30048523 [Abstract] [Full Text] [Related]
6. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing. Zheng Y, Dong X, Chen S, He Y, An J, Liu M, He L, Zhang Y. BMC Oral Health; 2023 Jan 10; 23(1):14. PubMed ID: 36627695 [Abstract] [Full Text] [Related]
7. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study. Hasegawa T, Hayashida S, Kondo E, Takeda Y, Miyamoto H, Kawaoka Y, Ueda N, Iwata E, Nakahara H, Kobayashi M, Soutome S, Yamada SI, Tojyo I, Kojima Y, Umeda M, Fujita S, Kurita H, Shibuya Y, Kirita T, Komori T, Japanese Study Group of Co-operative Dentistry with Medicine (JCDM). Osteoporos Int; 2019 Jan 10; 30(1):231-239. PubMed ID: 30406309 [Abstract] [Full Text] [Related]
11. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats. Bolette A, Lecloux G, Rompen E, Albert A, Kerckhofs G, Lambert F. J Craniomaxillofac Surg; 2019 Feb 10; 47(2):349-356. PubMed ID: 30595476 [Abstract] [Full Text] [Related]
12. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts. Zhao N, Li QX, Wang YF, Qiao Q, Huang HY, Guo CB, Guo YX. BMC Oral Health; 2023 May 27; 23(1):330. PubMed ID: 37245004 [Abstract] [Full Text] [Related]
15. Further development of the MRONJ minipig large animal model. Otto S, Pautke C, Martin Jurado O, Nehrbass D, Stoddart MJ, Ehrenfeld M, Zeiter S. J Craniomaxillofac Surg; 2017 Sep 27; 45(9):1503-1514. PubMed ID: 28803745 [Abstract] [Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M. Cancer Treat Rev; 2018 Sep 27; 69():177-187. PubMed ID: 30055439 [Abstract] [Full Text] [Related]
19. Application of mesenchymal stromal cell sheets to prevent medication-related osteonecrosis of the jaw with titanium implants in rats. Nishimaki K, Kaibuchi N, Washio K, Yamato M. Odontology; 2024 Jul 27; 112(3):938-949. PubMed ID: 38367068 [Abstract] [Full Text] [Related]
20. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P. Urol Nurs; 2016 Jul 27; 36(3):111-6, 154. PubMed ID: 27501591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]